Clinical Trial: Diagnostic Efficacy and Predictive Model Construction of Oral Gastrointestinal Ultrasound Contrast Agent Combined with Tumor Markers for Gastric Cancer Risk Based on Machine Learning Methods (China)

China, Sept. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Diagnostic Efficacy and Predictive Model Construction of Oral Gastrointestinal Ultrasound Contrast Agent Combined with Tumor Markers for Gastric Cancer Risk Based on Machine Learning Methods'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132435

Registration Time: 2026/09/14

Type: Diagnostic test

Primary Sponsor: The First Hospital of Putian

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=324680

Published by HT Digital Content Services with permission from Health Daily Digest....